Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, with a primary focus on neuromuscular diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:ALBPS.
$0.42 +0.01 (1.83%)
As of 03/22/2023 10:28:49 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.